Two Texas compounding pharmacies are the latest to get sued in Eli Lilly’s multistate battle to stop sales of replica ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The pharmacy argued in its ...
Hosted on MSN
Eli Lilly’s bid to overturn $183.7M Medicaid fraud award denied in appeals court ruling
Eli Lilly (NYSE:LLY) must pay $183.7M as damages in a lawsuit alleging that the Indiana-based drugmaker defrauded the Medicaid drug pricing program, a federal appeals court ruled on Thursday, ...
A Delaware federal judge dismissed a lawsuit brought by Eli Lilly, the maker of the blockbuster weight loss drugs Mounjaro and Zepbound, against a telehealth company it accused of “deceptive” ...
A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...
Eli Lilly and Co. and federal prosecutors are exploring a settlement of an investigation into the drugmaker's marketing of its top seller, the anti-psychotic Zyprexa, The New York Times reported. NEW ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results